Research at Iroko is focused on developing responsible pain management treatment options to address the problem of pain across the globe. One of the ways Iroko uniquely contributes to addressing pain is by using proprietary SoluMatrix Fine Particle Technology™ to create low-dose NSAID products.

These products align with recommendations set forth by FDA and other regulatory authorities as well as professional medical organizations regarding NSAID dosing: Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.